BioMar Raises 2026 EBIT Guidance to DKK 1.29–1.36 Billion
BioMar raised its 2026 EBIT guidance to DKK 1.29–1.36 billion.
Related stories
How to Spot an Earnings Trade That Costs too Much
Before you tell me a stock is going to explode after earnings, I want to know how much movement the options...
H impact | EARNINGS | Nov 02, 2026, 06:00 PM UTC
Marico Raises Full-Year Growth Targets After Strong Q2
Marico reported a strong July-September quarter and raised its full-year growth targets. The body is truncated before the revised targets are specified.
M impact | EARNINGS | Nov 02, 2026, 05:48 PM UTC
Coloplast Reports 6% Organic Growth for FY 2025/26
Coloplast reported 4% EBIT growth in constant currencies and 4% revenue growth in DKK, including a 2-percentage-point negative currency impact. Prior-period comparisons were not pr
M impact | EARNINGS | Nov 02, 2026, 05:42 PM UTC
Coloplast Expects 5–7% Organic Growth in FY 2026/27
M impact | EARNINGS | Nov 02, 2026, 05:40 PM UTC
Coloplast Sets 2030 Organic Revenue Growth and EBIT Margin Targets
Coloplast targets annual organic revenue growth of 5–7% and an EBIT margin in the mid-20% range through 2030.
M impact | EARNINGS | Nov 02, 2026, 05:39 PM UTC
Coloplast Expects FY 2026/27 EBIT Margin Around 25%
M impact | EARNINGS | Nov 02, 2026, 05:39 PM UTC